<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53785">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02086331</url>
  </required_header>
  <id_info>
    <org_study_id>13/LO/0943</org_study_id>
    <secondary_id>13HH0684</secondary_id>
    <nct_id>NCT02086331</nct_id>
  </id_info>
  <brief_title>Evaluation of Musculoskeletal Microcirculation With Ultrasound</brief_title>
  <acronym>EMMU</acronym>
  <official_title>Evaluation of Musculoskeletal Microcirculation With Ultrasound</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <authority>United Kingdom: Research Ethics Committee Imperial College London</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to validate the use of Dynamic Contrast-Enhanced Ultrasound in measuring the
      blood supply to the muscles of the leg, and how this changes with exercise and vascular
      pathology.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We propose a model for the use of Dynamic Contrast-Enhanced Ultrasound (DCEU) to directly
      evaluate the microcirculation of the musculoskeletal system. We believe that this will be a
      valuable research tool into diseases of the microcirculation, and in the future may also
      offer a clinical benefit by quantifying and monitoring disease over time and after
      intervention. It may also allow targeting of therapies towards those patients most at risk
      of ulcers and peripheral neuropathy, and those that would get the maximum benefit from these
      therapies.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Change in microcirculation</measure>
    <time_frame>20 mins on a treadmill (2% gradient)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in microcirculation (DCEUS ultrasound gastrocnemius and tibialis anterior) between baseline and post-exercise. )</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intra-group differences</measure>
    <time_frame>20 minutes on a treadmill( 2% gradient)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Differences in mean microcirculation values between groups (baseline to post-exercise)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Standardised Claudication Treadmill Test</condition>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy volunteers, deemed to have normal metabolic and cardiovascular biology by trial criteria</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PAD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Symptomatic peripheral arterial disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Symptomatic diabetic peripheral neuropathy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Contrast enhanced ultrasound</intervention_name>
    <description>Infusion of microbubbles to enhance blood vessels in the leg for ultrasound</description>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>PAD</arm_group_label>
    <arm_group_label>DM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Treadmill test</intervention_name>
    <description>Exposes you to exercise in a controlled environment. We will see if we can detect this change with our new ultrasound protocol</description>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>PAD</arm_group_label>
    <arm_group_label>DM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Contrast enhanced ultrasound</intervention_name>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>PAD</arm_group_label>
    <arm_group_label>DM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Group 1 - Healthy subjects Inclusion - 18+ years old Exclusion - Personal history of
        diabetes or peripheral arterial disease, current pregnancy, previous surgery to the lower
        limb, heart attack within 4 weeks, or unstable angina

        Group 2 - Peripheral arterial disease subjects Inclusion - 18+ years old, radiological
        evidence of peripheral arterial disease (arterial doppler or angiogram), ankle-brachial
        pressure index (ABPI) 0.5-0.8 Exclusion - Personal history of diabetes, current pregnancy,
        previous amputation, heart attack within 4 weeks, or unstable angina

        Group 3 - Diabetic subjects Inclusion - 18+ years old, with a clinical diagnoses of
        diabetes (1, 2) Exclusion - ABPI&lt;0.9, previous amputation, current pregnancy or
        breastfeeding, heart attack within 4 weeks, or unstable angina.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prof AH Davies</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kate Williams, MBBS</last_name>
    <phone>07970 412137</phone>
    <email>k.williams@imperial.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Charing Cross Hospital</name>
      <address>
        <city>London</city>
        <zip>W6 8RF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kate Williams, MBBS</last_name>
      <phone>07970 412137</phone>
      <email>k.williams@imperial.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Kate Williams, MBBS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>March 11, 2014</lastchanged_date>
  <firstreceived_date>January 9, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
